Cooperative binding of Ets-1 and core binding factor to DNA.
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Two phorbol ester-inducible elements (beta E2 and beta E3) within the human T-cell receptor beta gene enhancer each contain consensus binding sites for the Ets and core binding factor (CBF) transcription factor families. Recombinant Ets-1 and purified CBF bound individually to beta E2 and beta E3, in which the Ets and core sites are directly adjacent. In this report, we show that CBF and Ets-1 bind together to beta E2 and beta E3 and that Ets-1-CBF-DNA complexes are favored over the binding of either protein alone to beta E2. Formation of Ets-1-CBF-DNA complexes increased the affinity of Ets-1-DNA interactions and decreased the rate of dissociation of CBF from DNA. Ets-1-CBF-DNA complexes were not observed when either the Ets or core site was mutated. The spatial requirements for the cooperative interaction of Ets-1 and CBF were analyzed by oligonucleotide mutagenesis and binding site selection experiments. Core and Ets sites were coselected, and there appeared to be little constraint on the relative orientation and spacing of the two sites. These results demonstrate that CBF and Ets-1 form a high-affinity DNA-binding complex when both of their cognate sites are present and that the relative spacing and orientation of the two sites are unimportant. Ets and core sites are found in several T-cell-specific enhancers, suggesting that this interaction is of general importance in T-cell-specific transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · cited 1×
“Additional Ets family members, E74, GABPat, and PEA3 (6, 17, 18, 40), have been purified and cloned on the basis of their ability to bind to specific DNA sequences.”
BackgroundDalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
A structural taxonomy of DNA-binding domains
Harrison, S. C. (1991) · Nature · doi:10.1038/353715a0 · Cited by 608
A putative second cell-derived oncogene of the avian leukaemia retrovirus E26
Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., & Stehelin, D. (1983) · Nature · doi:10.1038/306395a0 · Cited by 459 · cited 1×
“The v-ets oncogene was identified as part of the genome of the E26 virus (19, 22) and has been shown to be derived from the chicken gene encoding Ets-1.”
MethodConvergence of Ets- and Notch-Related Structural Motifs in a Heteromeric DNA Binding Complex
Thompson, C. C., Brown, T. A., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1876833 · Cited by 455 · cited 2×
“GABPa binds only weakly to the herpes simplex virus immediate-early promoter, except in the presence of GABP, (18, 32), which also interacts with DNA.”
BackgroundSpi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447 · cited 1×
“1, the product of the Spi-1 (21) gene, and Fli-1 (1) were identified at sites of integration of either spleen focus-forming virus or Moloney murine leukemia virus (MLV).”
BackgroundEts-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF
Hipskind, R. A., Roa, V. N., Muller, C. G. F., Raddy, E. S. P., & Nordheim, A. (1991) · Nature · doi:10.1038/354531a0 · Cited by 430 · cited 4×
“SAP-1 (7) was isolated by its ability to form a ternary complex with serum response factor (SRF) on DNA containing a serum response element (SRE), a property also shared by Elk-1 (13).”
BackgroundInfluentialTripartite structure of the avian erythroblastosis virus E26 transforming gene
Nunn, M. F., Seeburg, P. H., Moscovici, C., & Duesberg, P. H. (1983) · Nature · doi:10.1038/306391a0 · Cited by 423 · cited 1×
“The v-ets oncogene was identified as part of the genome of the E26 virus (19, 22) and has been shown to be derived from the chicken gene encoding Ets-1.”
MethodBurtis, K. C., Thummel, C. S., Jones, C. W., Karim, F. D., & Hogness, D. S. (1990) · Cell · doi:10.1016/0092-8674(90)90217-3 · Cited by 409 · cited 1×
“Additional Ets family members, E74, GABPat, and PEA3 (6, 17, 18, 40), have been purified and cloned on the basis of their ability to bind to specific DNA sequences.”
BackgroundBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Research works printed but not linked: 1
- Hipskind R. A., Rao V. N., Mueller C. G., Reddy E. S., Nordheim A. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature. 1991 Dec 19;354(6354):531–534. doi: 10.1038/354531a0. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 101–200 of 218
Shin, B., Hosokawa, H., Romero-Wolf, M., Zhou, W., Masuhara, K., Tobin, V. R., Levanon, D., Groner, Y., & Rothenberg, E. V. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019655118 · Cited by 55
Puig-Kröger, A., Sánchez-Elsner, T., Ruiz, N., Andreu, E. J., Prosper, F., Jensen, U. B., Gil, J., Erickson, P., Drabkin, H., Groner, Y., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0618 · Cited by 51
Structural basis of Ets1 activation by Runx1
Shrivastava, T., Mino, K., Babayeva, N. D., Baranovskaya, O. I., Rizzino, A., & Tahirov, T. H. (2014) · Leukemia · doi:10.1038/leu.2014.111 · Cited by 51
Zaiman, A., & Lenz, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5618-5629.1996 · Cited by 53
“Binding studies with purified CBF and Ets-1 showed cooperative DNA binding by these two factors (103).”
BackgroundFowler, M., Borazanci, E. H., McGhee, L., Pylant, S. W., Williams, B. J., Glass, J., Davis, J. N., & Meyers, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20664 · Cited by 54
“Since the RUNX family is known to cooperate with Ets proteins to achieve maximal activation of target promoters [Wotton et al., 1994; Kim et al., 1999], we investigated whether RUNX1”
BackgroundIeki, K., Matsukura, S., Kokubu, F., Kimura, T., Kuga, H., Kawaguchi, M., Odaka, M., Suzuki, S., Watanabe, S., Takeuchi, H. T., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1941.x · Cited by 51
Baum, C., Itoh, K., Meyer, J., Laker, C., Ito, Y., & Ostertag, W. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6323-6331.1997 · Cited by 52
Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., & Hirai, H. (1998) · Blood · doi:10.1182/blood.v91.5.1688 · Cited by 48
The ETS Family of Transcriptional Regulators
Ghysdael, J., & Boureux, A. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8889-9_2 · Cited by 48
Self-citationSpecial Article: Gene Rearrangements in Ewing's Sarcoma
Denny, C. T. (1996) · Cancer Investigation · doi:10.3109/07357909609018438 · Cited by 48
Definition of a T-Cell Receptor β Gene Core Enhancer of V(D)J Recombination by Transgenic Mapping
Tripathi, R. K., Mathieu, N., Spicuglia, S., Payet‐Bornet, D., Verthuy, C., Bouvier, G., Depetris, D., Mattéi, M., Hempel, W. M., & Ferrier, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.42-53.2000 · Cited by 47
“More intriguing, however, is the function of the second Etsand CBF-interacting element within bE6 which, like that in bE4, is heavily occupied in early thymocytes (Fig.”
BackgroundInfluentialTranscriptional regulation of T-cell genes during T-cell development
Leiden, J. M., & Thompson, C. B. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90096-5 · Cited by 50
AML and Ets proteins regulate the Iα1 germ-line promoter
Xie, X., Pardali, E., Holm, M., Sideras, P., & Grundström, T. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<488::aid-immu488>3.0.co;2-n · Cited by 46
AML1 Interconnected Pathways of Leukemogenesis: MOLECULAR BIOLOGY AND GENETICS
Michaud, J., Scott, H. S., & Escher, R. (2003) · Cancer Investigation · doi:10.1081/cnv-120018821 · Cited by 53
“This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc. Signaling molecules BLK B-lymphocyte specific tyro- sine kinase B cells Experimental [44] Pax5 [44] p21(WAF1;CKN1A) Cyclin-dependent kinase inhibitor 1A Not specific Experimental [46] High expression[5…”
BackgroundCoffman, J. A., Kirchhamer, C. V., Harrington, M. G., & Davidson, E. H. (1997) · Development · doi:10.1242/dev.124.23.4717 · Cited by 43
Regulation of T Cell Receptor δ Gene Rearrangement by CBF/PEBP2
Lauzurica, P., Zhong, X., Krangel, M. S., & Roberts, J. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1193 · Cited by 43
Transcriptional regulation of hemopoiesis
Barreda, D. R., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00035-0 · Cited by 45
Serdobova, I., Pla, M., Reichenbach, P., Sperisen, P., Ghysdael, J., Wilson, A., Freeman, J., & Nabholz, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1211 · Cited by 43
Self-citationKang, C.-J., Sheridan, C., & Koshland, M. E. (1998) · Immunity · doi:10.1016/s1074-7613(00)80534-8 · Cited by 41
The Runt Domain Transcription Factor, PEBP2/CBF, and its Involvement in Human Leukemia
Ito, Y., & Bae, S.-C. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8934-6_4 · Cited by 41
Zhang, Y., Ho, T. D.-H., Buchler, N. E. G., & Gordân, R. (2021) · Genome Research · doi:10.1101/gr.275145.120 · Cited by 40
“Cooperative interactions between TFs, which are typically driven by direct contacts between compatible protein domains, have been extensively studied (Wotton et al. 1994; Jolma et al. 2015; Morgunova and Taipale 2017).”
BackgroundPrecise Alignment of Sites Required for μ Enhancer Activation in B Cells
Nikolajczyk, B. S., Nelsen, B., & Sen, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4544 · Cited by 38
“Finally, a close juxtaposition of core-binding factor sites to other sites has been noted in the TCR b- and d-chain gene enhancers (21, 60).”
BackgroundExpression Pattern of the Ets-related Transcription Factor Elf-1
Bassuk, A. G., Barton, K., Anandappa, R. T., Lu, M. M., & Leiden, J. M. (1998) · Molecular Medicine · doi:10.1007/bf03401746 · Cited by 44
John, S., Marais, R., Child, R., Light, Y., & Leonard, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.743 · Cited by 35
“Since the binding sites for all these proteins are related, fine binding specificity may also be influenced by specific interactions with accessory proteins (5-13).”
Hornig, N., Rodens, P., Dörr, H. G., Hubner, N. C., Kulle, A. E., Schweikert, H., Welzel, M., Bens, S., Hiort, O., Werner, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00052 · Cited by 37
Impaired Generation of CD8+ Thymocytes in Ets-1-Deficient Mice
Clements, J. L., John, S. A., & Garrett‐Sinha, L. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.905 · Cited by 39
Brettingham‐Moore, K. H., Taberlay, P. C., & Holloway, A. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00499 · Cited by 36
“While early studies characterized RUNX1 as a transcriptional activator, and demonstrated co-operation between RUNX1 and a range of other transcription factors to drive promoter activity (32, 33).”
BackgroundZhang, L., Li, Z., Yan, J., Pradhan, P., Corpora, T., Cheney, M. D., Bravo, J., Warren, A. J., Bushweller, J. H., & Speck, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303972200 · Cited by 34
Self-citationOgihara, H., Kanno, T., Morii, E., Kim, D., Lee, Y., Sato, M., Kim, W., Nomura, S., Ito, Y., & Kitamura, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202844 · Cited by 44
“PEBP2 and Ets also synergistically transactivate T cell receptor a promoter (Wotton et al., 1994; Sun et al., 1995; Giese et al., 1995; Kim et al., in press).”
BackgroundStructural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA
Babayeva, N. D., Wilder, P. J., Shiina, M., Mino, K., Desler, M. M., Ogata, K., Rizzino, A., & Tahirov, T. H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12257 · Cited by 36
RUNX3-Mediated Immune Cell Development and Maturation
Botó, P., Csuth, T. I., & Szatmári, I. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018025488 · Cited by 31
Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3
Nieves, A., Levy, L., & Lenz, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1213-1219.1997 · Cited by 31
“In the case of Mo-MuLV, the activity of CBF required the binding of a member of the Ets family of factors to the Ets (LVb) site (38, 42).”
BackgroundContext dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
Erman, B., & Sen, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00843.x · Cited by 33
Transcriptional network dynamics in early T cell development
Shin, B., Chang, S. J., MacNabb, B. W., & Rothenberg, E. V. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20230893 · Cited by 30
“…domain – dependent way during Phase 1 (Hosokawa et al., 2018b; Ungerb¨ack et al., 2018) as well as with Ets1 (Goetz et al., 2000; Gu et al., 2000; Wotton et al., 1994; Zhao et al., 2017), TCF-1 (Goldman et al., 2023; Shin et al., 2023), and Bcl11b in Phase 2 (Hosokawa et al., 2018a; Kojo et al.,…”
Runx1 Structure and Function in Blood Cell Development
Bonifer, C., Levantini, E., Kouskoff, V., & Lacaud, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_5 · Cited by 31
Rodríguez-Caparrós, A., Álvarez-Santiago, J., del Valle-Pastor, M. J., Suñé, C., López-Ros, J., & Hernández-Munaín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228478 · Cited by 30
Mechanism of ETV6-RUNX1 Leukemia
Sundaresh, A., & Williams, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_13 · Cited by 30
Hajra, A., Liu, P. P., Wang, Q., Kelley, C. A., Stacy, T., Adelstein, R. S., Speck, N. A., & Collins, F. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1926 · Cited by 29
Self-citationRetractedIto, Y. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01261402 · Cited by 36
“The central four nucleotides, 5'-CCRC, are most important, particularly when Ets-1 binds to the region near the PEBP2/CBF sites (Wotton et al. 1994).”
BackgroundAgarkar, V. B., Babayeva, N. D., Wilder, P. J., Rizzino, A., & Tahirov, T. H. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.017 · Cited by 29
Guan, Y., Yang, Y. J., Nagarajan, P., & Ge, Y. (2020) · Experimental Dermatology · doi:10.1111/exd.14247 · Cited by 28
“[126] Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ.”
BackgroundLi, X., Vradii, D., Gutiérrez, S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Javed, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20548 · Cited by 30
“A large number of co-regulatory proteins associate physically with specific domains of Runx1 and are functionally important for regulation of target genes [Wotton et al., 1994; Giese et al., 1995; Hiebert et al., 1996; Rhoades et al., 1996; Petrovick et al., 1998; Rubnitz and Look, 1998; Osato et al., 1999].”
BackgroundLiu, H., Holm, M., Xie, X., Wolf‐Watz, M., & Grundström, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403173200 · Cited by 29
Regulation of Human B19 Parvovirus Promoter Expression by hGABP (E4TF1) Transcription Factor
Vassias, I., Hazan, U., Michel, Y. M., Sawa, C., Handa, H., Gouya, L., & Morinet, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8287 · Cited by 27
Type B Leukemogenic Virus Has a T-Cell-Specific Enhancer That Binds AML-1
Mertz, J. A., Mustafa, F., Meyers, S., & Dudley, J. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2174-2184.2001 · Cited by 30
TEL GENE REARRANGEMENTS IN MYELOID MALIGNANCY
Golub, T. R. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70490-1 · Cited by 28
Tcra Enhancer Activation by Inducible Transcription Factors Downstream of Pre-TCR Signaling
del Blanco, B., Mariscal, A. G., Wiest, D. L., & Hernández-Munaín, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100271 · Cited by 26
“complex formed by the factors bound to Ta2 seems to be very stable based on in vitro (24) and in vivo studies (25, 47) because the binding sites at Ta2 facilitate cooperative protein binding to DNA (24, 25, 67).”
BackgroundHiebert, S. W., Reed-Inderbitzin, E. F., Amann, J. M., Irvin, B. J., Durst, K. L., & Linggi, B. E. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00021-4 · Cited by 30
Hernández-Munaín, C., & Krangel, M. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4362 · Cited by 27
“Moreover, CBF/PEBP2 binds cooperatively to naked DNA with Ets-1 or C/EBP in vitro (28, 31), but does not do so with c-Myb (12, 32).”
BackgroundHighly Cooperative Recruitment of Ets-1 and Release of Autoinhibition by Pax5
Fitzsimmons, D., Lukin, K., Lutz, R., Garvie, C. W., Wolberger, C., & Hagman, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.028 · Cited by 25
“4a-b, recruitment of Ets-1(331– 440) by Pax5(1-149)WT or Q22A occurred at different KDs (0.”
BackgroundSugimoto, H., Okamura, K., Sugimoto, S., Satou, M., Hattori, T., Vance, D. E., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503578200 · Cited by 27
Structure of the leukemia-associated human CBFB gene
Hajra, A. K., & Collins, F. S. (1995) · Genomics · doi:10.1016/0888-7543(95)80177-n · Cited by 24
RetractedRegulation of gene expression at early stages of B-cell and T-cell differentation
Fitzsimmons, D., & Hagman, J. R. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80054-9 · Cited by 28
SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b
Varshney, B., Agnihotram, S., Tan, Y., Baric, R. S., & Lal, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029542 · Cited by 25
“It synergises with other transcription factors to activate transcription [36,37,38] and acts as a transcriptional activator or repressor depending upon its association with co-activators such as CBP, p300, MOZ [39,40] and co-repressors, mSin3A [41], TLE1 [42,43] and NCoR [28].”
BackgroundShiina, M., Hamada, K., Inoue-Bungo, T., Shimamura, M., Uchiyama, A., Baba, S., Sato, K., Yamamoto, M., & Ogata, K. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.020 · Cited by 29
“Previous studies indicate that functional cooperativitymaybemediated byEts1–Runx1protein–protein interaction [15,28,29].”
Ethelberg, S., Lovmand, J., Schmidt, J., Luz, A., & Pedersen, F. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7273-7280.1997 · Cited by 23
“Constellations of Myb sites, AML1 sites, and Ets factor sites can be found in other T-cell-specific enhancers, and there is evidence for a cooperative effect between the interacting factors in some such enhancers, including the SL3-3 enhancer (15, 31, 42, 43, 52, 53).”
BackgroundHomologs of RUNX and CBFβ/PEBP2β in C. elegans
Lee, J., Ahnn, J., & Bae, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207669 · Cited by 26
“…factors such as the Groucho/TLE family proteins (Aronson et al., 1997; Imai et al., 1998; Oncogene Levanon et al., 1998) and with coactivator proteins such as ETS, Myb, and C/EBP (Wotton et al., 1994; Zhang et al., 1996; Mao et al., 1999; McCarthy et al., 2000; Martensson et al., 2001).”
BackgroundGranger, S. W., & Fan, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8961-8970.1998 · Cited by 26
“In addition, the pattern of in vivo protection at the LVb and Core sites obtained here agreed with the in vitro methylation interference data generated when recombinant Ets-1 and CBF were used (49).”
BackgroundMethodRegulation of the human LAT gene by the Elf-1 transcription factor
Finco, T. S., Justice, G. E., Patel, S. J., & Hamilton, V. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-4 · Cited by 22
“Both Runx and Ets proteins contain intramolecular inhibitory domains that can impede DNA binding and studies have shown that Runx-1 and certain members of the Ets family, namely Ets-1, MEF, and NERF [32,34,36-38,53], can interact with each other, displacing the inhibitory domains and thereby stimulating DNA binding an…”
BackgroundThe human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells
Arman, M., Aguilera‐Montilla, N., Mas, V., Puig‐Kröger, A., Pignatelli, M., Guigó, R., Corbí, A. L., & Lozano, F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.018 · Cited by 26
Roles of RUNX Complexes in Immune Cell Development
Ebihara, T., Seo, W., & Taniuchi, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_24 · Cited by 22
Duality of Enhancer Functioning Mode Revealed in a Reduced TCRβ Gene Enhancer Knockin Mouse Model
Bonnet, M., Huang, F., Benoukraf, T., Cabaud, O., Verthuy, C., Boucher, A., Jaeger, S., Ferrier, P., & Spicuglia, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902179 · Cited by 22
“Such sequences may, for example, include the additional ETS/RUNX composite E 6 module (46, 49).”
BackgroundRunx Protein Signaling in Human Cancers
Anglin, I. E., & Passaniti, A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_10 · Cited by 21
Characterization of the human and mouse Fli-1 promoter regions
Barbeau, B., Bergeron, D., Beaulieu, J., Nadjem, Z., & Rassart, É. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00060-7 · Cited by 24
Nimer, S. D., Zhang, W., Kwan, K. W., Whang, Y. E., Zhang, J., & Whang, Y. W. Y. C. T. (1996) · Blood · doi:10.1182/blood.v87.9.3694.bloodjournal8793694 · Cited by 21
The roles of Runx1 in skeletal development and osteoarthritis: A concise review
Liu, Y., Huang, C., Bai, M., Pi, C., Zhang, D., & Xie, J. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12656 · Cited by 21
Martin, V., Zhuang, F., Zhang, Y., Pinheiro, K., & Gordân, R. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad872 · Cited by 20
“These interactions are flexible and occur at various distances and orientations ( 26 ,44 ) .”
BackgroundMethodResultInfluentialStructural Basis of Ets1 Cooperative Binding to Widely Separated Sites on Promoter DNA
Babayeva, N. D., Baranovskaya, O. I., & Tahirov, T. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033698 · Cited by 23
“Ets1 autoinhibition is counteracted by direct interaction of the DNA-binding domain and/or autoinhibitory regions with regulatory partners, including Pax5 [11], Runx1 [20,21,22,23,24] and Runx2 [25,26], or by DNA-mediated homodimerization [27,28,29].”
BackgroundT-cell receptor α enhancer is inactivated in αβ T lymphocytes
del Blanco, B., Angulo, Ú., Krangel, M. S., & Hernández-Munaín, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406551112 · Cited by 20
“Within this segment, the Tα1-Tα2 region contains essential binding sites for cAMP response element bindingprotein (CREB), T-cell factor 1 (TCF-1)/lymphocyte enhancer factor 1/(LEF-1), Runx-1, and Ets-1 (19), and cooperative binding Significance The Tcra enhancer (Eα) is essential during thymocyte development for Tcra…”
BackgroundBehan, K. J., Fair, J., Singh, S., Bogwitz, M. R., Perry, T., Grubor, V. D., Cunningham, F., Nichols, C. D., Cheung, T. L., Batterham, P., et al. (2005) · Development Genes and Evolution · doi:10.1007/s00427-005-0490-0 · Cited by 20
“Such a protein complex relaxes autoinhibition of both RUNX1 and Ets-1, and results in cooperative binding of both proteins to DNA (Wotton et al. 1994; Erman et al. 1998; Kim et al. 1999; Goetz et al. 2000; Gu et al. 2000; Dittmer 2003).”
BackgroundTani‐ichi, S., Satake, M., & Ikuta, K. (2011) · International Immunology · doi:10.1093/intimm/dxr055 · Cited by 20
Stepwise Commitment from Embryonic Stem to Hematopoietic and Endothelial Cells
Park, C., Lugus, J. J., & Choi, K. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)66001-2 · Cited by 20
Chih, D. Y., Park, D. J., Gross, M. E., Idos, G., Vuong, P. T., Hirama, T., Chumakov, A. M., Said, J. W., & Koeffler, H. P. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.08.014 · Cited by 20
“In particular, various stages of myelopoiesis and functional activation of mature myeloid cells are regulated by several members of the basic helix loop helix proteins, basic region-leucine zipper (bZIP) proteins, zinc finger proteins, AML1, Myb, and Ets family of transcription factors [2–10].”
BackgroundDevelopmental Relationship Between Hematopoietic and Endothelial Cells
Lugus, J. J., Park, C., & Choi, K. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:057 · Cited by 19
Activation of Mouse Tcrb: Uncoupling RUNX1 Function from Its Cooperative Binding with ETS1
Zhao, J., Osipovich, O. A., Koues, O. I., Majumder, K., & Oltz, E. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700146 · Cited by 20
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation
Nielsen, A. L., Pallisgaard, N., Pedersen, F. S., & Jørgensen, P. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5638-5647.1994 · Cited by 19
“A synergistic binding of Ets-1 and the core-binding factor as observed in the T-cell receptor 3-gene enhancer may function for MLVs (73).”
BackgroundHuman α‐galactosidase A: High plasma activity expressed by the ‐30G→A allele
Fitzmaurice, T. F., Desnick, R. J., & Bishop, D. F. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005366224351 · Cited by 23
“Of note, the crystal structure of the canonical member of the Ets family, human Ets1, was recently solved (Werner et al 1995), providing insights into the nature of the observed DNA, Ets and accessory protein ternary complexes (Dalton and Treisman 1992; Wotton et al 1994; Werner et al 1995).”
BackgroundMaury, W. J., Bradley, S. E., Wright, B., & Hines, R. (2000) · Virology · doi:10.1006/viro.1999.0144 · Cited by 20
Yan regulates Lozenge during Drosophila eye development
Behan, K. J., Nichols, C. D., Cheung, T. L., Farlow, A., Hogan, B. M., Batterham, P., & Pollock, J. A. (2002) · Development Genes and Evolution · doi:10.1007/s00427-002-0241-4 · Cited by 18
Sugimoto, H., Sugimoto, S., Tatei, K., Obinata, H., Bakovic, M., Izumi, T., & Vance, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301590200 · Cited by 20
Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories
Kellaway, S. G., Keane, P., Edginton‐White, B., Regha, K., Kennett, E., & Bonifer, C. (2021) · Life Science Alliance · doi:10.26508/lsa.202000864 · Cited by 17
“RUNX1 functions by directly binding DNA together with its obligate partner CBFβ via the DBD, in large complexes mediated by the TAD (Koh et al, 2013; Petrovick et al, 1998; Wotton et al, 1994).”
BackgroundHajra, A. K., Liu, P., Speck, N. A., & Collins, F. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4980 · Cited by 16
“CBF-responsive promoters may be particularly susceptible to this inhibition, since CBF requires cooperation with several other transcription factors, including Ets-1 and c-Myb, for full gene regulation (22, 56, 62).”
BackgroundSelf-citationRetractedJacobs, P. T., Cao, L. H., Samon, J. B., Kane, C. A., Hedblom, E., Bowcock, A. M., & Telfer, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069083 · Cited by 14
“1, LEF-1, Myb and CEBPα [22,25,27,30,85,92]) or implicated in transcriptional silencing (AP4/ZEB E-box and RAP1 [86,87,93]) are identified [94].”
Backgrounddel Blanco, B., Roberts, J. L., Zamarreño, N., Devaux, N., & Hernández-Munaín, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803351 · Cited by 18
“These experiments indicated that TCF-1/LEF-1 factors must bind to this enhancer in vivo in conjunction with Ets-1 (and presumably Runx1, which binds in a highly cooperative fashion with Ets-1 in vitro) in an all or none fashion (36, 38, 45, 81) that explained why intact T 2 TCF/LEF and ets sites are both essential for…”
BackgroundLaguna, T., Notario, L., Pippa, R., Fontela, M. G., Vázquez, B. N., Maicas, M., Aguilera‐Montilla, N., Corbí, A. L., Odero, M. D., & Lauzurica, P. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.031 · Cited by 14
Watanabe, S., Ito, Y., Miyajima, A., & Arai, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9615 · Cited by 13
Schmidt, H. M., Steger, G., & Pfister, H. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.8029-8034.1997 · Cited by 13
“Synergistic activation of promoters by Ets-1 and CBF has been described previously (8, 36) and might represent one of the diverse possibilities for fine tuning the expression of viral proteins.”
BackgroundLi, Raouf, A., Kitching, A. R., & Seth, A. K. (2004) · PubMed · Cited by 12
Regulation of immunoglobulin gene transcription
Calame, K. L., & Ghosh, S. (1995) · Elsevier eBooks · doi:10.1016/b978-012053640-5/50021-5 · Cited by 13
Structure and Biophysics of CBFβ/RUNX and Its Translocation Products
Tahirov, T. H., & Bushweller, J. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_2 · Cited by 12
Correction: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b
Varshney, B., Agnihothram, S., Tan, Y., Baric, R. S., & Lal, S. K. (2012) · PLoS ONE · doi:10.1371/annotation/64ae6047-0f9b-4d17-a065-e08c153aa435 · Cited by 12
Solution properties of the free and DNA‐bound Runt domain of AML1
Wolf‐Watz, M., Xie, X., Holm, M., Grundström, T., & Härd, T. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00269.x · Cited by 10
Lineage specificity of CBFA2 fusion transcripts
Dann, E. J., Fears, S. C., Arád-Dann, H., Nucifora, G., & Rowley, J. D. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00150-2 · Cited by 9
“We and others have shown that it regulates the promoters of genes involved in hematopoietic differentiation [12–20].”
BackgroundMorii, E., Ogihara, H., Kanno, T., Kim, D., Nomura, S., Ito, Y., & Kitamura, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0996 · Cited by 11
Ethelberg, S., Tzschaschel, B. D., Luz, A., Díaz‐Cano, S. J., Pedersen, F. S., & Schmidt, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10406-10415.1999 · Cited by 8
Gene Regulation in T-Cell Lineage Commitment
Rothenberg, E. V. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_18 · Cited by 8
Cho, S.-J., & Kang, C.-J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.167 · Cited by 6
Huang, F., Cabaud, O., Verthuy, C., Hueber, A., & Ferrier, P. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01691.x · Cited by 6
Transforming Properties of the Leukemic Inv(16) Fusion Gene CBFB-MYH11
Hajra, A. K., Liu, P. P., & Collins, F. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_29 · Cited by 4
Organization and Rearrangement of TCR Loci
Aschauer, C., Outters, P., & Ferrier, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.05010-4 · Cited by 4
Metadata
- Authors
- Wotton, D., Ghysdael, J., Wang, S., Speck, N. A., & Owen, M. J.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1994-01
- Volume
- 14
- Issue
- 1
- Pages
- 840-850
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC358432
- OpenAlex
- W2119973182
- Cited by
- 216
- References
- 40
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 7 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 7
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- Leukemia Research Foundation
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- National Institutes of Health (5r29ca051065-05)
- Norris Cotton Cancer Center
- National Cancer Institute (CA51065-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Diffusion and Search Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- ETS1, core binding factor, cooperative DNA binding, transcription factor-DNA complex, enhancer binding sites, DNA binding affinity
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cattle, Chickens, Cloning, Molecular, DNA, DNA-Binding Proteins, Enhancer Elements, Genetic, Humans, Kinetics, Molecular Sequence Data, Neoplasm Proteins, Proto-Oncogene Proteins, Transcription Factors, Receptors, Antigen, T-Cell, alpha-beta, DNA, Complementary, Core Binding Factors, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.